Menu Search
Equities

Upexi Inc

7TQ0:DEU

Upexi Inc

Actions
  • Price (EUR)3.80
  • Today's Change0.00 / 0.00%
  • Shares traded96.85
  • 1 Year change-78.53%
  • Beta--
Data delayed at least 15 minutes, as of Oct 02 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Upexi, Inc. is a multi-faceted brand owner with brands in the health, wellness, pet, beauty, and other growing markets. The Company focuses on direct-to-consumer and Amazon brands. The Company utilizes its in-house software-as-a-service (SaaS) programmatic advertising technology to help achieve a lower cost per acquisition and accumulate consumer data for increased cross-selling between its growing portfolio of brands. Its Branded Product segment is focused on the development, growth, and distribution of the branded products that the Company own. Its Recommerce segment is focused on the purchase and sale of new and used products through channels, such as Amazon and wholesale distributors. The Company’s brands include VitaMedica, Tytan Tiles, and others. VitaMedica offers clinician-originated nutraceuticals and cosmeceuticals products. VitaMedica’s sales model includes wholesale distribution through surgeons and med spas and direct to consumers through e-commerce and marketplaces.

  • Revenue in USD (TTM)77.40m
  • Net income in USD-21.54m
  • Incorporated2018
  • Employees95.00
  • Location
    Upexi Inc3030 Rocky Point Drive, Suite 420TAMPA 33607United StatesUSA
  • Phone+1 (701) 353-5425
  • Websitehttps://upexi.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.